Clinical Stage Pharmaceutical Company
At Dermal Bright, our mission is to transform the treatment landscape for chronic skin conditions through scientific innovation and a deep commitment to patient needs.
We are dedicated to developing targeted therapies that go beyond symptomatic relief, addressing the underlying biological pathways that drive these often life-altering disorders.
By advancing both systemic and topical solutions, we seek to offer safer, more durable, and more effective options for patients who have long faced limited choices and high rates of recurrence.
Through rigorous research, patient-centered development, and a relentless pursuit of better outcomes, we aim to restore confidence, improve quality of life, and set a new standard of care in dermatology.
At Dermal Bright, we are redefining how chronic skin diseases are treated.
Focused initially on one of the most challenging and underserved dermatologic conditions, we are developing therapies that go beyond symptom management to address underlying biological causes.
Our team brings together expertise in dermatology, immunology, and pharmaceutical innovation to create solutions that are both scientifically advanced and patient-centered.
Through our oral and topical therapeutic programs — DB-01 and DB-02 — we aim to provide safer, more durable, and more effective treatment options for patients worldwide affected by chronic skin diseases.
Driven by science and inspired by the real, unmet needs of patients, Dermal Bright is committed to setting a new standard of care in dermatology.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.